Srđan Verstovšek

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 30 papers. Top paper: “10-day decitabine with venetoclax for newly diagnosed intensive chemotherapy ineligible, and relapsed or refractory acute myeloid leukaemia: a single-centre, phase 2 trial”.

10-day decitabine with venetoclax for newly diagnosed intensive chemotherapy ineligible, and relapsed or refractory acute myeloid leukaemia: a single-centre, phase 2 trial

The Lancet Haematology(2020)10.1016/s2352-3026(20)30210-6

N/A

6.4DataRank · unranked

334 citations

Abhishek Maiti, Caitlin R. Rausch, Naveen Pemmaraju, Kiran Naqvi, Naval Daver +34 more

Prognostic value of measurable residual disease after venetoclax and decitabine in acute myeloid leukemia

Blood Advances(2021)10.1182/bloodadvances.2020003717

N/A

3.2DataRank · unranked

82 citations

Courtney D. DiNardo, Sa A. Wang, Jeffrey L. Jorgensen, Tapan M. Kadia, Naval Daver +28 more

Safety and efficacy of avapritinib in advanced systemic mastocytosis: the phase 1 EXPLORER trial

Nature Medicine(2021)10.1038/s41591-021-01538-9

N/A

0.753DataRank · unranked

150 citations

Deepti Radia, Tracy I. George, William A. Robinson, Albert Quiery, Mark W. Drummond +13 more

A phase 1/2 study of ruxolitinib and decitabine in patients with post-myeloproliferative neoplasm acute myeloid leukemia

Leukemia(2020)10.1038/s41375-020-0778-0

N/A

0DataRank · unranked

52 citations

Srđan Verstovšek, Jörge E. Cortes, Susan Tse, Yvonne Gasior, Nitin Jain +19 more

Long‐term results of a phase 2 trial of nilotinib 400 mg twice daily in newly diagnosed patients with chronic‐phase chronic myeloid leukemia

Cancer(2020)10.1002/cncr.32623

N/A

0DataRank · unranked

21 citations

Jörge E. Cortes, Keyur P. Patel, Susan O’Brien, Graciela M. Nogueras‐González, Marina Konopleva +11 more

Prevalence of pulmonary hypertension in myelofibrosis

Annals of Hematology(2020)10.1007/s00277-020-03962-2

N/A

0DataRank · unranked

19 citations

Srđan Verstovšek, Bryan Fellman, Cezar Iliescu, Karan Bhatti, Saamir Hassan +7 more

Altered T-cell subset repertoire affects treatment outcome of patients with myelofibrosis

Haematologica(2020)10.3324/haematol.2020.249441

N/A

0DataRank · unranked

18 citations

Sanja Prijić, Taghi Manshouri, Graciela M. Nogueras‐González, Srđan Verstovšek, Zeev Estrov +1 more

Novel Concepts of Treatment for Patients with Myelofibrosis and Related Neoplasms

Cancers(2020)10.3390/cancers12102891

N/A

0DataRank · unranked

16 citations

Lucia Masárová, Srđan Verstovšek, Prithviraj Bose

Long‐term results of frontline dasatinib in chronic myeloid leukemia

Cancer(2020)10.1002/cncr.32627

N/A

0DataRank · unranked

34 citations

Jörge E. Cortes, Keyur P. Patel, Lucia Masárová, Gautam Borthakur, Farhad Ravandi +14 more

miR-543 regulates the epigenetic landscape of myelofibrosis by targeting TET1 and TET2

JCI Insight(2020)10.1172/jci.insight.121781

N/A

0DataRank · unranked

25 citations

Recep Bayraktar, Taghi Manshouri, Andréia Maria da Silva, Cristina Ivan, Diana Gulei +25 more

Clinical value of event-free survival in acute myeloid leukemia

Blood Advances(2020)10.1182/bloodadvances.2019001150

N/A

0DataRank · unranked

7 citations

Hagop M. Kantarjian, Vinita Popat, Gautam Borthakur, Guillermo Garcia‐Manero, Marina Konopleva +16 more

Single-center experience with venetoclax combinations in patients with newly diagnosed and relapsed AML evolving from MPNs

Blood Advances(2021)10.1182/bloodadvances.2020003934

N/A

0DataRank · unranked

48 citations

Courtney D. DiNardo, Prithviraj Bose, Naveen Pemmaraju, Naval Daver, Tapan M. Kadia +7 more

Accelerated Phase of Myeloproliferative Neoplasms

Acta Haematologica(2021)10.1159/000512929

N/A

0DataRank · unranked

41 citations

Helen T. Chifotides, Prithviraj Bose, Lucia Masárová, Srđan Verstovšek, Omar Shahin

Avapritinib for Systemic Mastocytosis

Expert Review of Hematology(2021)10.1080/17474086.2021.1959315

N/A

0DataRank · unranked

28 citations

Srđan Verstovšek, Prithviraj Bose

SOHO State of the Art Updates and Next Questions: Identifying and Treating “Progression” in Myelofibrosis

Clinical Lymphoma Myeloma & Leukemia(2021)10.1016/j.clml.2021.06.008

N/A

0DataRank · unranked

13 citations

Srđan Verstovšek, Prithviraj Bose

STAT3 induces the expression of GLI1 in chronic lymphocytic leukemia cells

Oncotarget(2021)10.18632/oncotarget.27884

N/A

0DataRank · unranked

11 citations

David Harris, Ping Li, Zhiming Liu, Preetesh Jain, Taghi Manshouri +10 more

Momelotinib: an emerging treatment for myelofibrosis patients with anemia

Journal of Hematology & Oncology(2022)10.1186/s13045-021-01157-4

N/A

0DataRank · unranked

89 citations

Prithviraj Bose, Srđan Verstovšek, Helen T. Chifotides

An International, Retrospective Study of Off-Label Biologic Use in the Treatment of Hypereosinophilic Syndromes

The Journal of Allergy and Clinical Immunology In Practice(2022)10.1016/j.jaip.2022.02.006

N/A

0DataRank · unranked

37 citations

Florence Roufosse, Sa A. Wang, Srđan Verstovšek, Sandy Durrani, Marc E. Rothenberg +19 more

GLI1 activates pro-fibrotic pathways in myelofibrosis fibrocytes

Cell Death and Disease(2022)10.1038/s41419-022-04932-4

N/A

0DataRank · unranked

20 citations

Ivo Veletić, Ping Li, C. Cameron Yin, Sean M. Post, Srđan Verstovšek +2 more

Mutational landscape of blast phase myeloproliferative neoplasms (MPN-BP) and antecedent MPN

International review of cell and molecular biology(2022)10.1016/bs.ircmb.2021.02.008

N/A

0DataRank · unranked

19 citations

Helen T. Chifotides, Srđan Verstovšek, Prithviraj Bose, Sergiu Paşca

Disease Modification in Myelofibrosis: An Elusive Goal?

Journal of Clinical Oncology(2022)10.1200/jco.21.02246

N/A

0DataRank · unranked

26 citations

Srđan Verstovšek, Prithviraj Bose, Pankit Vachhani

Characteristics of patients with myelofibrosis on ruxolitinib for three or more years.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.e19082

N/A

0DataRank · unranked

0 citations

Prithviraj Bose, Naveen Pemmaraju, Helen T. Chifotides, Lingsha Zhou, Zeev Estrov +3 more

Association of Myelofibrosis Phenotypes with Clinical Manifestations, Molecular Profiles, and Treatments

Cancers(2023)10.3390/cancers15133331

N/A

0DataRank · unranked

22 citations

Srđan Verstovšek, Prithviraj Bose, Helen T. Chifotides

Safety and efficacy of zinpentraxin alfa as monotherapy or in combination with ruxolitinib in myelofibrosis: stage I of a phase II trial

Haematologica(2023)10.3324/haematol.2022.282411

N/A

0DataRank · unranked

17 citations

Lynda Foltz, Vikas Gupta, Robert P. Hasserjian, Taghi Manshouri, John Mascarenhas +15 more

Cytopenic myelofibrosis: prevalence, relevance, and treatment

Expert Opinion on Pharmacotherapy(2023)10.1080/14656566.2023.2203318

N/A

0DataRank · unranked

14 citations

Srđan Verstovšek, Prithviraj Bose, Pankit Vachhani

SOHO State of the Art Updates and Next Questions: Novel Therapeutic Strategies in Development for Myelofibrosis

Clinical Lymphoma Myeloma & Leukemia(2023)10.1016/j.clml.2022.12.014

N/A

0DataRank · unranked

8 citations

Lucia Masárová, Srđan Verstovšek, Helen T. Chifotides

CLL Cell-Derived Exosomes Impair Immune Function and Normal Hematopoiesis in CLL

Blood(2023)10.1182/blood-2023-190712

N/A

0DataRank · unranked

1 citations

David Harris, Uri Rozovski, Ping Li, Zhiming Liu, Taghi Manshouri +15 more

Sotatercept for anemia of myelofibrosis: a phase II investigator-initiated study

Haematologica(2024)10.3324/haematol.2023.284078

N/A

0DataRank · unranked

15 citations

Lucia Masárová, Naveen Pemmaraju, Sharon Bledsoe, Naval Daver, Elias Jabbour +19 more

Survival following allogeneic transplant in patients with myelofibrosis

Blood Advances(2020)10.1182/bloodadvances.2019001084

N/A

0DataRank · unranked

97 citations

Karen K. Ballen, Kwang Woo Ahn, Zhen‐Huan Hu, Haris Ali, Murat O. Arcasoy +63 more

Mechanistic basis and efficacy of targeting the β-catenin–TCF7L2–JMJD6–c-Myc axis to overcome resistance to BET inhibitors

Blood(2020)10.1182/blood.2019002922

N/A

0DataRank · unranked

73 citations

Warren Fiskus, Christopher P. Mill, Dimuthu Perera, Taghi Manshouri, Bernardo H Lara +18 more